• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观点:为什么我们需要为低收入国家提供即时 CD4 检测?

Viewpoint: Why do we need a point-of-care CD4 test for low-income countries?

机构信息

Médecins sans Frontières, Operational Centre Brussels, Operational Research Unit, Medical Department, MSF- Luxembourg, Luxembourg.

出版信息

Trop Med Int Health. 2011 Jan;16(1):37-41. doi: 10.1111/j.1365-3156.2010.02669.x. Epub 2010 Nov 2.

DOI:10.1111/j.1365-3156.2010.02669.x
PMID:21371207
Abstract

In this paper, we discuss the reasons why we urgently need a point-of-care (POC) CD4 test, elaborate the problems we have experienced with the current technology which hampers CD4-count coverage and highlight the ideal characteristics of a universal CD4 POC test. It is high-time that CD4 technology is simplified and adapted for wider use in low-income countries to change the current paradigm of restricted access once and for all.

摘要

在本文中,我们讨论了为什么我们迫切需要一个即时护理(POC)CD4 检测,详细阐述了目前阻碍 CD4 计数覆盖的技术所带来的问题,并强调了通用 POC CD4 检测的理想特征。现在是时候简化 CD4 技术并将其应用于低收入国家以扩大使用范围,从而彻底改变目前这种受限的获取模式。

相似文献

1
Viewpoint: Why do we need a point-of-care CD4 test for low-income countries?观点:为什么我们需要为低收入国家提供即时 CD4 检测?
Trop Med Int Health. 2011 Jan;16(1):37-41. doi: 10.1111/j.1365-3156.2010.02669.x. Epub 2010 Nov 2.
2
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.低收入和中等收入国家抗逆转录病毒疗法的合理使用:优化治疗方案的排序与转换
AIDS. 2008 Oct 18;22(16):2053-67. doi: 10.1097/QAD.0b013e328309520d.
3
Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.科特迪瓦 HIV-1 感染患者开始高效抗逆转录病毒治疗的标准和短期免疫应答。
HIV Med. 2009 Nov;10(10):640-6. doi: 10.1111/j.1468-1293.2009.00736.x. Epub 2009 Jul 29.
4
The use of total lymphocyte count (TLC) as an independent criterion for initiating HAART in resource-poor countries.在资源匮乏国家将总淋巴细胞计数(TLC)用作启动高效抗逆转录病毒治疗(HAART)的独立标准。
J Infect. 2005 Jan;50(1):66-7. doi: 10.1016/j.jinf.2003.11.011.
5
Antiretroviral therapy: unmet need and associated socio-demographic characteristics among HIV-positive women in Haiphong, Vietnam.抗逆转录病毒疗法:越南海防市艾滋病毒阳性女性中未满足的需求及相关社会人口学特征
AIDS Care. 2011 Jan;23(1):1-9. doi: 10.1080/09540121.2010.496846.
6
Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.服务提供点的免费护理:发展中国家实现普遍获得艾滋病毒/艾滋病治疗的关键组成部分。
AIDS. 2008 Jul;22 Suppl 1:S161-8. doi: 10.1097/01.aids.0000327637.59672.02.
7
National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?资源有限国家的成人抗逆转录病毒治疗国家指南:与2003年世界卫生组织指南的一致性?
AIDS. 2006 Jul 13;20(11):1497-502. doi: 10.1097/01.aids.0000237365.18747.13.
8
Rapid scaling-up of access to antiretroviral therapy in Mexico: Is it better not to treat?墨西哥抗逆转录病毒疗法可及性的快速扩大:不进行治疗会更好吗?
AIDS. 2007 Jan 11;21(2):261-2. doi: 10.1097/QAD.0b013e3280112220.
9
Use of total lymphocyte count for monitoring response to antiretroviral therapy.使用总淋巴细胞计数监测抗逆转录病毒治疗的反应。
Clin Infect Dis. 2004 Jan 15;38(2):257-62. doi: 10.1086/380792. Epub 2003 Dec 18.
10
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.在慢性HIV-1感染患者中,根据CD4细胞计数和血浆HIV-1 RNA水平指导抗逆转录病毒治疗中断。
AIDS. 2007 Jan 11;21(2):169-78. doi: 10.1097/QAD.0b013e328011033a.

引用本文的文献

1
Artificial intelligence-enabled microfluidic cytometer using gravity-driven slug flow for rapid CD4 T cell quantification in whole blood.利用重力驱动的段塞流实现全血中CD4 T细胞快速定量的人工智能微流控细胞仪。
Microsyst Nanoeng. 2025 Feb 28;11(1):36. doi: 10.1038/s41378-025-00881-y.
2
Effectiveness of the credit-line approach for support of CD4 equipment functionality in northern Uganda.信贷额度方法对支持乌干达北部CD4设备功能的有效性。
Afr J Lab Med. 2015 Nov 30;4(1):234. doi: 10.4102/ajlm.v4i1.234. eCollection 2015.
3
Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection.
HAART 前 CD4+ T 淋巴细胞可作为 HIV 感染儿童(合并或不合并结核分枝杆菌感染)HAART 后免疫恢复的生物标志物。
BMC Infect Dis. 2020 Oct 15;20(1):756. doi: 10.1186/s12879-020-05458-w.
4
Point of Care Diagnostics in Resource-Limited Settings: A Review of the Present and Future of PoC in Its Most Needed Environment.资源有限环境下的即时诊断检测:即时检测在最急需的环境中的现状和未来综述。
Biosensors (Basel). 2020 Sep 24;10(10):133. doi: 10.3390/bios10100133.
5
Performance characteristics of an instrument-free point-of-care CD4 test (VISITECT®CD4) for use in resource-limited settings.无仪器即时检测点 CD4 检测(VISITECT®CD4)在资源有限环境中的性能特点。
J Int Med Res. 2020 Sep;48(9):300060520955028. doi: 10.1177/0300060520955028.
6
Diagnosis of Human Immunodeficiency Virus Infection.人类免疫缺陷病毒感染的诊断。
Clin Microbiol Rev. 2018 Nov 28;32(1). doi: 10.1128/CMR.00064-18. Print 2019 Jan.
7
Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube.评价皮马 CD4 即时检测的标本类型:EDTA 微量采血管指血采集的优势。
PLoS One. 2018 Aug 23;13(8):e0202018. doi: 10.1371/journal.pone.0202018. eCollection 2018.
8
Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.孕期当日启动抗逆转录病毒治疗(ART)与病毒抑制或参与护理无关:一项队列研究。
J Int AIDS Soc. 2018 Jun;21(6):e25133. doi: 10.1002/jia2.25133.
9
PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa.在南非德班夸祖鲁 - 纳塔尔省,针对HIV感染者,使用PIMA™即时检测CD4计数来预测抗逆转录病毒治疗的起始情况。
South Afr J HIV Med. 2016 Jun 24;17(1):444. doi: 10.4102/sajhivmed.v17i1.444. eCollection 2016.
10
The validity of the biological eligibility criteria to antiretroviral treatment in comparison to the systematic antiretroviral treatment in a cohort of people living with the HIV in the Southern Kivu Province, Democratic Republic of the Congo.在刚果民主共和国南基伍省的一组艾滋病毒感染者中,与系统性抗逆转录病毒治疗相比,抗逆转录病毒治疗生物学资格标准的有效性。
Pan Afr Med J. 2016 Dec 6;25:210. doi: 10.11604/pamj.2016.25.210.9799. eCollection 2016.